were prepared by chemical synthesis (Biopeptek Inc, Malvern, USA or GenScript, Piscataway, USA): NIH peptide (YPNVNIHNF) for H2-Ld (7); P18-I10 peptide (RGPGRAFVTI) for H2-Dd (8); NRASQ61K peptide (ILDTAGKEEY) for HLA-A*01:01 (9); TAX peptide (LLFGYPVYV) for HLA-A*02:01 (10) . The luminal domain of TAPBPR was expressed using a Drosophila S2 cell expression system and purified as previously described (11) . All purified proteins were exhaustively buffer exchanged into 100 mM NaCl, 20 mM sodium phosphate pH 7.2.
X-ray crystallography. P18-I10/H2-Dd Y84C-A139C/hβ2m crystals were grown by the sitting drop method and plates were incubated at 22°C. Crystals were obtained by mixing 1 μL of protein at 12 mg/mL with an equal volume of reservoir solution (0.2M ammonium acetate, 0.1M Bis-Tris pH 5.5 and 25% (v/v) PEG 3350). Reservoir solution supplemented with 20% (v/v) glycerol used as a cryoprotectant. Data were collected at the Advanced Photon Source, Argonne National Laboratory, at beamline 23-IDB. Diffraction images were indexed, integrated, and scaled using Mosflm and Aimless in the CCP4 package (12) . Structures were determined by Phaser (13) using PDB ID 3ECB as a search model. Model building and refinement were performed using COOT (14) and Phenix (15) , respectively. The structural model and structure factors were deposited into the Protein Data Bank under accession code 6NPR.
Differential Scanning Fluorimetry. DSF experiments were performed on an Applied Biosystems ViiA 7 qPCR machine with excitation and emission wavelengths set to 470 nm and 569 nm with proteins in buffer of 100 mM NaCl, 20 mM sodium phosphate pH 7.2. Experiments were conducted in triplicate in MicroAmp Fast 96-well plates with 50 μL total volume containing final concentrations of 7 μM protein and 10× SYPRO orange dye (ThermoFisher). Temperature was incrementally increased at a scan rate of 1°C/min between 25°C and 95°C. Data analysis and fitting were performed in GraphPad Prism v7.
SEC Binding Assays.
Size exclusion chromatography (SEC) binding assays were performed using a mixture of 80 µM pMHC-I and 80 µM TAPBPR (1:1 molar ratio) that were incubated at room temperature for 1 hour. SEC binding was performed on a Superdex 200 Increase 10/300 GL column at flow rate 0.5 mL/min in 100 mM NaCl, 20 mM sodium phosphate pH 7.2.
ITC experiments.
Isothermal titration calorimetry (ITC) experiments between pMHC-I and TAPBPR constructs were obtained using a MicroCal VP-ITC system (Malvern Panalytical). All proteins were exhaustively dialyzed into the buffer (50 mM NaCl, 20 mM sodium phosphate pH 7.2) filtered through a 0.22 μm PES membrane. Syringe containing pMHC-I at concentrations of 100 to 150 μM were titrated into calorimetry cell containing 12 μM TAPBPR and 1 mM purified free peptide (NRASQ61K for HLA-A*01:01, TAX for HLA-A*02:01, P18-I10 for H2-Dd and p29 for H2-Ld). Injection volumes were 10 μL performed for a duration of 10 sec and spaced 220 sec apart to allow for a complete return to baseline. Data was subtracted from a control performed where syringe containing pMHC-I at concentrations of 100 to 150 μM were titrated into calorimetry cell containing buffer and 1 mM purified free peptide. Data were processed and analyzed with Origin software. Isotherms were fit using a one-site ITC binding model. The first data point was excluded from analysis. Reported KD, -T*ΔS, and ΔH values are the average values from two technical replicates. NMR Chemical Shift Assignments. Samples for NMR were prepared using AILV methyl (Ala 13Cβ, Ile 13Cδ1, Leu 13Cδ1/13Cδ2, Val 13Cγ1/13Cγ2) labeling at the heavy chain of H2-Dd, H2-Ld, HLA-A*02:01 or HLA-A*01:01 pMHC-I molecules, on a 12C/2H/15N background (6) . Resonance assignments were derived separately for each pMHC-I system from a series of 3D experiments recorded at 800 MHz and 25ºC (6, 16) . Briefly, backbone amide resonances were assigned using standard, TROSY-based 3D HNCO, HNCA and HN(CA)CB experiments recorded at 800 MHz at 25ºC. Backbone amide assignments were further validated through amide-amide NOEs, acquired in 3D HN-NHN and 3D N-NHN SOFAST NOESY experiments (3). Unambiguous assignments of methyl resonances were obtained on the basis of the backbone assignments, using 3D HMCM[CG]CBCA out-and-back methyl-TROSY experiments recorded on 500 μM to 1 mM pMHC-I samples prepared with an alternative ILV methyl labelling scheme (ILV*) which aims to generate a linear 13C labelling pattern at the side chains of Leu and Val spin systems for optimal sensitivity (18) . AILV methyl assignments were validated and stereospecifically disambiguated by acquiring methyl-methyl NOEs in 3D HM-CMHM and 3D CM-CMHM SOFAST NOESY experiments (17) . All 3D SOFAST NOESY experiments were acquired using standard parameters (16) . To confirm the assignment of the TAPBPR bound pMHC-I states for the sidechain methyl resonances, an additional 3D HM-CMHM experiment was acquired with 200 µM pMHC-I/TAPBPR complexes and compared to similar NOE strips from the unbound pMHC-I reference. All NMR data were processed with NMRPipe (4) and analyzed using NMRFAM-SPARKY (5).
NMR Titrations and Chemical Shift
Mapping. NMR chemical shift mapping of different pMHC-I/TAPBPR complexes was performed in a manner analogous to our established characterization of the H2-Dd system (6) . Briefly, 105 µM pMHC-I was titrated with increasing concentrations of unlabeled TAPBPR in matched NMR buffer (100 mM NaCl, 20 mM sodium phosphate pH 7.2, 10% D2O (v/v), 1U Roche protease inhibitor). pMHC-I:TAPBPR molar ratios were 1:0, 1:0.59, 1:1.18, 1:1.77, 1:2.36, and 1:2.95. Two-dimensional 1H-13C methyl SOFAST HMQC experiments recorded at 25ºC at a 1H field strength of 800 MHz were used as readouts. A total number of 136 scans were used with a 0.2 sec recycle delay (d1) and acquisition times of 30 ms in the 13C dimension. To compare with the SOFAST experiments, an additional titration between 105 µM pMHC-I with pMHC-I:TAPBPR molar ratios were 1:0, 1:0.59, 1:1.18, 1:1.77, 1:2.36, and 1:2.95 was performed using standard (non-SOFAST) version of the 2D 1H-13C HMQC experiment recorded at 25ºC at a 1H field strength of 800 MHz with 28 scans were used with a 0.8 sec recycle delay (d1) and acquisition times of 30 ms in the 13C dimension. Data were processed with 4 Hz and 10 Hz Lorentzian line broadening in the direct and indirect dimensions, respectively, and fit using a two-state binding model in TITAN (21) with bootstrap error analysis of 100 replicas. Chemical shift deviations (CSD, p.p.m.) were determined using the equation ΔδCH3=[1/2(ΔδH2+ΔδC2/4)]1/2 for 13C AILV methyls. The |Δδ 13C| was determined by taking the absolute value of the difference between the 13C chemical shift of the free and TAPBPR bound pMHC-I states.
CPMG Relaxation Dispersion. AILV methyl sidechain relaxation dispersion profiles were obtained using 1H to 13C single-quantum Carr-Purcell-Meiboom-Gill (CPMG) relaxation dispersion experiments (22) on samples with concentrations ranging from 500 μM to 1 mM perdeuterated pMHC-I samples recorded at 25ºC at 600 MHz and 800 MHz. A temperature calibration using the temperature-dependence of the water resonance, relative to an internal 4,4-demethyl-4-silapentane-1-sulfonic acid (DSS) standard was used to ensure strict temperature matching between the two instruments operating at different magnetic fields. Spectra were recorded in an interleaved manner with CPMG field strengths of 50, 100, 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, 800, 900 and 1000 Hz with a constant time delay (TCPMG) of 40 ms. Peak intensities obtained using NMRFAM-SPARKY were converted to the R2, eff transverse decay rates with the equation R2, eff = 1/TCPMG × ln (I0 / IνCPMG). Only with nonoverlapping resonances were analyzed. CPMG profiles were fitted with a two-state, global model of all methyl groups displaying dispersion (Rex > 1 s-1) using the program CATIA, which further allows for a correction of off-resonance effects of the CPMG 180º pulse train (http://www.biochem.ucl.ac.uk/hansen/catia/).
Fluorescence Anisotropy. Fluorescence anisotropy (r, herein referred to as FA) was performed using a P18-I10 peptide labeled with TAMRA dye (KTAMRAGPGRAFVTI, herein called TAMRA-P18-I10) (Biopeptek Inc.) (6) . Graded concentrations (0 μM, 0.05 μM, 0.1 μM, 0.25 μM, 0.5 μM and 1 μM) of TAPBPR were added to a mixture of 0.75 nM TAMRA-P18-I10 and either 0.1 μM of wild-type P18-I10/H2-Dd/hβ2m or P18-I10/H2-Dd Y84C-A139C/hβ2m. The average FA after incubation for 95-105 min at room temperature (25 °C) was plotted as a function of the log10 of concentration of TAPBPR. Each experiment was performed at room temperature in a volume of 100 μL and loaded onto a black 96-well polystyrene assay plate (Costar 3915). FA data were recorded via a PerkinElmer Envision 2103 plate reader with an excitation filter of λex = 531 nm and an emission filter of λem = 595 nm. Each experiment was performed in triplicate. Experimental values were subtracted from background FA values obtained from incubation of TAMRA-P18-I10 alone. All samples were prepared in matched buffer (100 mM NaCl, 20 mM sodium phosphate pH 7.2, 0.05% (v/v) tween-20). Data analysis and fitting was performed in GraphPad Prism v7.
Rosetta modeling. Rosetta's comparative modeling protocol was used to generate MHC-I/TAPBPR complexes using the H2-Dd/β2m/TAPBPR crystal structure as a template (23, 24) .
High resolution structure refinement of the resulting models were carried out using Rosetta's relax protocol (25) .
Additional Acknowledgements. We acknowledge the Lewis Kay (University of Toronto) lab for providing the SQ 13C-CPMG pulse sequences, Flemming Hansen (University College London) for aid with CPMG fitting in CATIA, Hsiau-Wei Lee (UCSC) for assistance in acquiring NMR experiments at 600 MHz, Kannan Natarajan (NIAID) for providing the S2 cell lines for TAPBPR protein expression and Tilini Wijeratne and Giora Morozov (UCSC) for help with protein expression and purification. Cell sorting and deep sequencing were conducted at the Roy J. Carver Biotechnology Center (Illinois) with assistance from Barbara Pilas, Barbara Balhan, Christy Wright, and Alvaro Hernandez. We are thankful to Kannan Natarajan and David Margulies (NIAID) for helpful discussions throughout the course of this study. (26) and processed with ESPript (27) . Secondary structure of the heavy chain from H2-Dd (PDB ID 3ECB) is provided for reference. Residues in blue boxes are conserved. The red asterisk (*) denotes heavy chain residues that are in direct contact with TAPBPR based on the structure of H2-Dd and TAPBPR (PDB 5WER) as calculated with the software Protein Interfaces, Surfaces and Assemblies (PISA) (28) . (22) recorded at 25°C (800 MHz -blue ; 600 MHzpurple) on AILV methyl labeled (at the heavy chain) pMHC-I. Methyl groups of each heavy chain in specified regions, including the (A) A-pocket, (B) α2-1 helix, and (C) α3 domain, exhibit allele-specific conformational exchange. Flat profiles indicate no observable μs-ms dynamics, compared to profiles exhibiting "curve" behavior, which are undergoing significant conformational exchange. The effective transverse relaxation rate (R2eff, s-1, y-axis) is shown as a function of the CPMG pulse frequency (νCPMG, Hz, x-axis). For each pMHC-I molecule the global fit of the relaxation dispersion curves performed in CATIA (http://www.biochem.ucl.ac.uk/hansen/catia/) are shown. Upper and lower error bars of R2eff were determined based on the spectral noise. The fitted |Δω| values are noted in each panel and can also be found in Table S2 . 
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